Which adults with non-ST-elevation acute coronary syndromes are eligible for Aggrastat (tirofiban hydrochloride monohydrate) to prevent early myocardial infarction?

Aggrastat, with acetylsalicylic acid and unfractionated heparin, is indicated for adults with NSTE-ACS, last chest pain within 12 hours, and ECG changes and/or elevated cardiac enzymes; patients at high myocardial-infarction risk within 3–4 days of acute angina onset, including those likely to undergo early PCI, are most likely to benefit.